157 related articles for article (PubMed ID: 18930330)
41. Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients.
Inamine T; Higa S; Noguchi F; Kondo S; Omagari K; Yatsuhashi H; Tsukamoto K; Nakamura M
J Gastroenterol; 2013 Oct; 48(10):1160-70. PubMed ID: 23354620
[TBL] [Abstract][Full Text] [Related]
42. [Genetic association of tumor necrosis factor (TNF)-alpha polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population].
Fan LY; Zhong RQ; Tu XQ; Pfeiffer T; Feltens R; Zhu Y; Zhou L
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):160-2. PubMed ID: 15059302
[TBL] [Abstract][Full Text] [Related]
43. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis.
Zhao J; Zhao S; Zhou G; Liang L; Guo X; Mao P; Zhou X; Wang H; Nan Y; Xu D; Yu J
Scand J Gastroenterol; 2011 Apr; 46(4):485-94. PubMed ID: 21275501
[TBL] [Abstract][Full Text] [Related]
44. Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
Chen L; Borozan I; Milkiewicz P; Sun J; Meng X; Coltescu C; Edwards AM; Ostrowski MA; Guindi M; Heathcote EJ; McGilvray ID
Liver Int; 2008 Aug; 28(7):997-1010. PubMed ID: 18422935
[TBL] [Abstract][Full Text] [Related]
45. Primary biliary cholangitis: pathogenic mechanisms.
Prieto J; Banales JM; Medina JF
Curr Opin Gastroenterol; 2021 Mar; 37(2):91-98. PubMed ID: 33332913
[TBL] [Abstract][Full Text] [Related]
46. Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis.
Donaldson P; Veeramani S; Baragiotta A; Floreani A; Venturi C; Pearce S; Wilson V; Jones D; James O; Taylor J; Newton J; Bassendine M
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):755-60. PubMed ID: 17482523
[TBL] [Abstract][Full Text] [Related]
47. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
[TBL] [Abstract][Full Text] [Related]
48. [Regulation of hepatobiliary transporters in cholestatic liver disease].
Geier A; Gartung C; Matern S
Med Klin (Munich); 2004 Jan; 99(1):7-17. PubMed ID: 14716480
[TBL] [Abstract][Full Text] [Related]
49. NFKB1 and MANBA Confer Disease Susceptibility to Primary Biliary Cholangitis via Independent Putative Primary Functional Variants.
Hitomi Y; Nakatani K; Kojima K; Nishida N; Kawai Y; Kawashima M; Aiba Y; Nagasaki M; Nakamura M; Tokunaga K
Cell Mol Gastroenterol Hepatol; 2019; 7(3):515-532. PubMed ID: 30528300
[TBL] [Abstract][Full Text] [Related]
50. Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations.
Tanaka A; Nezu S; Uegaki S; Kikuchi K; Shibuya A; Miyakawa H; Takahashi S; Bianchi I; Zermiani P; Podda M; Ohira H; Invernizzi P; Takikawa H
J Hepatol; 2009 Jun; 50(6):1202-9. PubMed ID: 19376604
[TBL] [Abstract][Full Text] [Related]
51. Value of baseline platelet count for prediction of complications in primary biliary cirrhosis patients treated with ursodeoxycholic acid.
Huang YL; Yao DK; Hu ZD; Sun Y; Chen SX; Zhong RQ; Deng AM
Scand J Clin Lab Invest; 2013 Feb; 73(1):17-23. PubMed ID: 23294193
[TBL] [Abstract][Full Text] [Related]
52. Primary biliary cirrhosis: does X mark the spot?
Selmi C; Invernizzi P; Miozzo M; Podda M; Gershwin ME
Autoimmun Rev; 2004 Nov; 3(7-8):493-9. PubMed ID: 15546796
[TBL] [Abstract][Full Text] [Related]
53. Chemokine receptor 5 and primary biliary cirrhosis: a two-centre genetic association study.
Baragiotta A; Floreani A; Agarwal K; Venturi C; Craggs A; Jones DE; Donaldson PT; Bassendine MF
Liver Int; 2004 Dec; 24(6):646-50. PubMed ID: 15566517
[TBL] [Abstract][Full Text] [Related]
54. Genetic factors in the pathogenesis of primary biliary cirrhosis.
Jones DE; Donaldson PT
Clin Liver Dis; 2003 Nov; 7(4):841-64. PubMed ID: 14594133
[TBL] [Abstract][Full Text] [Related]
55. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
56. A polymorphism in the integrin αV subunit gene affects the progression of primary biliary cirrhosis in Japanese patients.
Inamine T; Nakamura M; Kawauchi A; Shirakawa Y; Hashiguchi H; Aiba Y; Taketomi A; Shirabe K; Nakamuta M; Hayashi S; Saoshiro T; Komori A; Yatsuhashi H; Kondo S; Omagari K; Maehara Y; Ishibashi H; Tsukamoto K;
J Gastroenterol; 2011 May; 46(5):676-86. PubMed ID: 21116829
[TBL] [Abstract][Full Text] [Related]
57. Primary biliary cirrhosis in Southern Israel: a 20 year follow up study.
Delgado JS; Vodonos A; Delgado B; Jotkowitz A; Rosenthal A; Fich A; Novack V
Eur J Intern Med; 2012 Dec; 23(8):e193-8. PubMed ID: 23022449
[TBL] [Abstract][Full Text] [Related]
58. Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis.
Joshita S; Umemura T; Tanaka E; Ota M
J Immunol Res; 2017; 2017():3073504. PubMed ID: 28255561
[TBL] [Abstract][Full Text] [Related]
59. When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis.
Fickert P; Trauner M
J Hepatol; 2009 Mar; 50(3):633-5. PubMed ID: 19157624
[TBL] [Abstract][Full Text] [Related]
60. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.
Hirschfield GM; Xie G; Lu E; Sun Y; Juran BD; Chellappa V; Coltescu C; Mason AL; Milkiewicz P; Myers RP; Odin JA; Luketic VA; Bacon B; Bodenheimer H; Liakina V; Vincent C; Levy C; Pillai S; Lazaridis KN; Amos CI; Siminovitch KA
Genes Immun; 2012 Jun; 13(4):328-35. PubMed ID: 22257840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]